In the present study, we characterized the function of HS1-binding protein 3 (HS1BP3), which is mutated in essential tremor and may be involved in lymphocyte activation. We found that HS1BP3 localized to the mitochondria and endoplasmic reticulum partially. Overexpression of HS1BP3 induced apoptosis in HEK293T and HeLa cell lines. When these cell lines were transfected with HS1BP3, they exhibited nuclear DNA condensation, externalization of phosphatidylserine (PS), and cleavage of poly ADP ribose polymerase (PARP). 
INTRODUCTION
The human gene HS1BP3 encodes a protein that binds to hematopoietic-specific protein 1 (HS1), an actin-binding and Src homology 3 (SH3) domain-containing protein. HS1 also expresses in a variety of tissues different from hematopoietic tissues (1) . HS1 is known as a major substrate of protein-tyrosine kinases following activation by B-cell or T-cell receptor complexes, and may play a role in cytoskeleton organization in both healthy and leukemic B-cells (2) . HS1BP3 expression is observed in various tissues and tissue-derived cell lines, and may be involved in lymphocyte activation (3) . In addition, HS1BP3 is mutated in essential tremor (ET), but is not associated with Parkinson's disease (4, 5) .
The nuclear transcription factor AP-1 has been linked to cellular proliferation, differentiation, transformation and apoptosis. AP-1 regulates various genes and itself is regulated by the phosphorylation of mitogen activated protein kinases (MAPKs), including c-Jun N-terminal kinase (JNK) (6) . AP-1 has been implicated various physiological and pathological events (7) (8) (9) (10) . In addition, increased c-Jun and c-Fos protein expression, as well as JNK activity, have been reported in many instances of apoptosis (11) (12) (13) . AP-1 is also required for ceramide-induced apoptosis (14) .
Here we analyzed function of HS1BP3 and found that it localizes to the mitochondria and endoplasmic reticulum (ER). In addition, HS1BP3 overexpression resulted in condensation of nuclear DNA, externalization of PS, cleavage of PARP and apoptosis in HEK293T and HeLa cell lines. Moreover, suppression of HS1BP3 or HS1 expression attenuates HS1BP3 induced apoptosis. In addition, HS1BP3 overexpression enhanced AP-1-mediated transcriptional activity in a dose-dependent manner. Therefore, HS1BP3 may act as a transcriptional activator in the AP-1 signaling pathway and regulate cell apoptosis via HS1.
RESULTS

Expression profiles of human HS1BP3
Previously, HS1BP3 was reported to be widely expressed (3) . RT-PCR analysis revealed differences in HS1BP3 expression levels among various cell types. We also observed HS1BP3 mRNA in some cell lines, including HeLa, THP-1, H520, PANC-1, EC9706 and 293, in addition to Raji, PAA, MGC803, Jurkat, U937, A549, HepG2, DU145 and HT29. But the expression in human ovarian carcinoma cell line SKov3 and human neuroblastoma cell line SH-sy5y were weak (Fig. 1A) .
HS1BP3 localizes to the mitochondria and ER partially
To determine the subcellular localization of HS1BP3, we constructed an HS1BP3-GFP fusion plasmid. We cotransfected it into HEK293T cells along with the pDsRed-Mito, pDsRed-ER or pDsRed-Golgi plasmids. As shown in Fig. 1B , partial co-localization of HS1BP3 and mitochondria or ER were observed. However, we did not observe any colocalization with the Golgi apparatus.
Overexpression of HS1BP3 reduces cell viability and inhibits cell growth
To evaluate the effect of human gene HS1BP3 on cell viability, we performed a fluorescent assay using Calcein-AM and EthD-1. Calcein-AM is a non-toxic compound that fluoresces when converted into a green fluorescent calcein by esterase http://bmbreports.org activity present in viable cells. Its fluorescence is, however, reduced when cells are lysed. In contrast, intact cell membranes are impermeable to the DNA stain EthD-1, which has a very strong red fluorescence upon binding to DNA, making it ideal for the detection of cells with compromised membranes and/or dead cells. Thus these dyes can be used to identify living and dead cells. The green/red fluorescence observed in transfected HEK293T cells is shown in Fig. 2A . The dead (red) cells transfected with HS1BP3 were obviously more than pcDB (empty vector control), Bcl-associated X protein (Bax)-transfected cells were used as positive control.
In addition, we performed an automated image analysis to detect the number of dead and living cells using the "Integrated Morphometry Analysis" application module of MetaMorph 6.3. As shown in Fig. 2B , both dead cells and the ratio of dead cells/living cells increased in HS1BP3-transfected cells compared with pcDB.
Meanwhile, we analyzed the effect of HS1BP3 overexpression on cell growth using a cholecystokinin 8 (CCK8) assay. It significantly inhibited the growth of HEK293T cells compared with pcDB ( Fig. 2C ). These results suggest that HS1BP3 overexpression reduces cell viability and inhibits cell growth.
Overexpression of HS1BP3 induces apoptosis
Relative to pcDB, HS1BP3-transfected HEK293T and HeLa cells were rounded, exhibited shrinkage and membrane blebbing, and detached from the culture dish (data not shown). Fluorescent microscopy of DAPI-stained cells revealed that HS1BP3-transfected cells showed chromatin condensation and were ruptured, especially in 48 hours post-transfection (Fig.  3A) . These morphological changes induced by HS1BP3 overexpression are hallmarks of apoptosis.
A key biochemical hallmark of apoptotic cell death is the translocation of PS from the cytoplasmic surface of the cell membrane to the external cell surface. The presence of PS at the surface of apoptotic cells can be easily identified by flow cytometry using fluorescently-labeled Annexin V, which specifically binds PS. Using FITC/Annexin-V staining, we detected PS on the surface of HEK293T cells 24 and 48 hours after transfection. Plasma membrane integrity was simultaneously assessed by PI exclusion using two-color fluorescence-activated cell sorting (FACS) analysis. As shown in Fig. 3B , HS1BP3 overexpression resulted in a significant increase in the number of Annexin V and/or PI-positive cells at 24 and 48 hours post-transfection. pcDB and Bax were used as the negative and positive control, respectively.
Overexpression of HS1BP3 activates caspase 3
Activation of effector caspases, such as caspase 3 and 7, is re-http://bmbreports.org BMB reports sponsible for the proteolytic cleavage of a diverse range of apoptotic structural and regulatory proteins. To determine whether HS1BP3 can activate caspase 3, we analyzed the cleavage of PARP, a substrate of caspase 3, by western blot. We readily detected cleaved PARP in HS1BP3-and Bax-transfected cells, but rarely detected it in pcDB-transfected cells (Fig. 3C) . The result strongly suggested that the caspase cascade is activated during HS1BP3-induced apoptosis.
Overexpression of HS1BP3 activates AP-1
Using a dual-luciferase reporter assay system, a dose-response assay was performed by transfecting HEK293T and HeLa cells with 0 to 240 ng of HS1BP3 expression vector (pcDB was added to ensure equal amounts of DNA in each transfection). We found that HS1BP3 overexpression activated the cis AP-1 reporter gene in a dose-dependent manner in HEK293T and HeLa cells, especially in HEK293T cells (Fig. 3D) .
Suppression of HS1BP3 expression attenuates HS1BP3 induced apoptosis
To further determine the role of HS1BP3 on apoptosis under physiological conditions, siRNAs were designed to silence HS1BP3 expression in cells. Non-silencing siRNA or siRNAs against HS1BP3 (siHS1BP3-1, 2 and 3) were transfected into cells alone or combined with the HS1BP3-GFP vector. At 24 hours after transfection, both HS1BP3 mRNA and protein levels significantly decreased in cells transfected with siHS1BP3-1, as assessed by fluorescence microscopy (Fig. 4A ) and RT-PCR (Fig. 4B) . Next, we evaluated the effect of siHS1BP3-1 on cell apoptosis. As shown in Fig. 4C , at 20, 44 and 68 hours after transfection, siHS1BP3-1 can significantly attenuate HS1BP3 induced apoptosis compared with non-silencing, as measured by the Annexin V/PI staining.
DISCUSSION
HS1BP3 binds to HS1 and other members of the 14-3-3 family of proteins, and selectively associates with the HS1 SH3 domain in vitro. (3, 15) The interaction between HS1 and HS1BP3 could be essential for lymphocyte function (3). Phosphorylated HS1 protein plays a crucial role in the B-cell receptor (BCR)-mediated pro-apoptotic signal transduction pathway (16, 17) . HS1 is phosphorylated by non-receptor-type protein-tyrosine kinases (NR-PTKs) upon crosslinking of surface immunoglobin M (sIgM), after which it translocates to the nucleus and regulates the transcription of target genes, such as c-myc, which are responsible for the apoptotic response (16) . In addition, HS1 is a substrate for caspase 3 and is cleaved during apoptosis, which may provide an efficient mechanism for regulating the actin cytoskeleton during the cell death process (18) . Interestingly, we found that overexpressed HS1BP3 induced multiple signs of apoptosis in HEK293T and HeLa cells, and the caspase cascade is activated during HS1BP3-induced apoptosis. Therefore, HS1 fragmentation during apoptosis, or cleavage of HS1 by caspases, might imply that HS1BP3 regulates the apoptosis pathway via HS1. Such is the fact, siHS1-2 assessed by RT-PCR (Fig. 4B) , was used to suppress HS1 expression, and we found that suppression of HS1 expression can also obviously attenuate HS1BP3 induced apoptosis (Fig.  4C) . However, further studies are needed to clarify whether HS1BP3 regulates tyrosine phosphorylation of HS1 through its immunoreceptor tyrosine-based inhibitory motif (ITIM)-like motifs and facilitates the degradation of HS1 through caspase activation. HS1BP3 might associate with the SH3 domain of HS1 in hematopoietic cells while binding to Cortactin or other Drebrinlike molecules through SH3 regions in non-hematopoietic cells (3) . Interestingly, an earlier study reported that hematopoietic protein kinase 1-interacting protein 55 kDa (HIP-55), another actin-binding and SH3 domain-containing protein, interacts with hematopoietic progenitor kinase 1 (HPK1) through its SH3 domain, leading to activation of JNK (19) . JNK activation is required for regulation of the stress-induced mitochondrial cell death pathway, and inactivates the anti-apoptotic functions of B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xl) via phosphorylation (20, 21) . We also found that HS1BP3 enhanced the transcriptional activity of AP-1 in a dose-dependent manner. This could imply that HS1BP3 binds to HIP-55 through its SH3 domain, thereby facilitating the activation of JNK, ultimately resulting in the activation of JNKregulated genes, including those involved in apoptosis.
Some studies have reported the association of a rare variant in the HS1BP3 gene with the ET phenotype (4, 5, 15) . However, the functional role of HS1BP3 and related proteins in the pathogenesis of ET is unknown. Here, we report that HS1BP3 may act as a transcriptional activator in the AP-1 signaling pathway and regulate cell apoptosis. We also noticed that mitochondria has been described as a place where numerous apoptosis-regulating molecules converge, especially the Bcl2 family members. Our results showed that HS1BP3 localizes to the mitochondria and ER partially, which indicate that HS1BP3 may be involved in a mitochondria/cytochrome c-or ER stressmediated cell apoptosis pathway. However, the precise location of HS1BP3 should be analyzed by confocal microscopy and western blot, and further studies are needed to fully understand the precise mechanisms underlying HS1BP3-mediated cell apoptosis as well as the interactions between HS1 and other apoptosis regulators in the near future. A better understanding of the physiological role of HS1BP3 may provide a platform for developing specific therapeutics for diseases such as ET.
MATERIALS AND METHODS
Reagents
EcoRI and BamHI restriction enzymes were purchased from Takara (China). Fluorescein isothiocyanate (FITC)-conjugated annexin V and propidium iodide (PI) were purchased from Beijing Biosea Biotechnology Co. (China). DAPI (4',6-diamidino-2-phenylindole) was purchased from Sigma (USA). Calcein-AM [4'5'-bis (N', N'-bis (carboxymethyl) aminomethyl fluorescein acetoxymethyl ester) and ethidium homodimer-1 (EthD-1) were obtained from Molecular Probes (Eugene, USA). Monoclonal antibody against PARP was obtained from Transduction Laboratories (USA), and one against glyceraldehyde 3 phosphate dehydrogenase (GAPDH) was purchased from Sigma (USA). IRDyeTM 800-conjugated secondary antibodies against mouse and rabbit IgG were purchased from LI-COR Bioscience (USA). Tetramethyl Rhodamine Isothiocyanate (TRITC)-conjugated secondary antibodies against mouse IgGs were purchased from Zhongshan (China).
cDNA Cloning and Expression Vector Construction
The full-length cDNA of human HS1BP3 (GenBank Accession No. NM_022460.3) was amplified from the mixed Matchmaker TM human cDNA library (Clontech, USA) using the forward primer P1 (5'-CCAACAAGTGTCTCCTCCAA-3') and reverse primer P2 (5'-ATAGTCTCATTCCAGCCAGT-3'). The purified PCR product was ligated into a pGEM-T Easy vector (Promega, USA) and confirmed by sequencing using an ABI PRISM Ⓡ 3100 Genetic Analyzer (Applied Biosystems, USA). http://bmbreports.org BMB reports
The insert fragment was subcloned into the EcoRI site of the mammalian expression vector pcDNA.3.1/myc-His (−) B (Invitrogen, USA) to construct the pcDB-HS1BP3 plasmid. To construct a recombinant HS1BP3-GFP fusion protein, forward P3 (5'-ccggaattccaccATGCAGTCCCCGGCGGT-3') and reverse P4 (5'-cgcggatccaaGAAGAGGCTGGGGGCGGCCT-3') primers were designed for PCR with pcDB-HS1BP3 as template. The underlined sequences in primers P3 and P4 are EcoRI and BamHI recognition sites, respectively. The purified PCR product was then digested and ligated into the EcoRI and BamHI sites of the pEGFP-N1 vector (Clontech, USA).
Reverse transcriptase-PCR (RT-PCR) analysis
The mRNA expression profile of HS1BP3 and HS1 were analyzed by RT-PCR. Total cellular RNA was extracted using TRIzol reagent (Invitrogen, USA), and first strand cDNA was prepared using the Superscript III system with an oligo (dT)15 primer (Invitrogen, USA). cDNA synthesis was checked by PCR, GAPDH was amplified as an internal control. The RT-PCR reaction was performed with the ThermoSCRIPT RT-PCR System (Invitrogen, USA) according to the manufacturer's protocol, and PCR products were analyzed via gel electrophoresis.
Subcellular localization analysis
HEK293T cells were plated on a 96-well plate. 24 hours later, pDsRed-Mito, pDsRed-ER or pDsRed-Golgi plasmids (Clontech, USA), which were used as markers of mitochondria, endoplasmic reticulum (ER) and Golgi, respectively, were co-transfected with HS1BP3-GFP plasmids using the Vigorous transfection reagent. Cells were then visualized 24 hours later with an inverted fluorescence microscope (Axiovert 200M, Zeiss, Germany).
Cell culture, transient transfection and dual-luciferase reporter assay
HEK293T (Human embryonic kidney cell line, a kind gift from T. Matsuda, Japan) and HeLa (Human cervical carcinoma cell line) cells were maintained in Dulbecco's modified Eagle medium (Life Technologies, USA) supplemented with 10% fetal bovine serum (FBS, Hyclone, USA) and L-glutamine (2 mM) at 37 o C in a humid incubator with 5% CO2. For the cis-luciferase reporter gene assays, HEK293T cells or HeLa cells were seeded on 96-well plates. After 18 hours, DNA transfection was performed using VigoFect (Vigorous, China), a non-liposomal cationic formula, according to the instructions provided by the manufacturer. A total of 284 ng plasmid DNA per well were used, including 240 ng of pcDB-HS1BP3 plasmid or pcDB (as empty vector control), 40 ng pAP1-Luc (Clontech, USA) which contains AP-1 binding sites, the firefly luciferase reporter gene. In addition, 4 ng pRL-TK (Promega, USA), which contains the renilla luciferase gene, was used as an internal control. Each experiment was performed in triplicate. The cells were lysed in standard lysis buffer 24 hours later (Promega, USA), and luciferase activity of total cell lysates was measured with the Dual-Luciferase Reporter Assay Kit (Promega, USA) according to the manufacturer's instructions, using a GENios Pro reader (Tecan, Switzerland). Firefly luciferase values were normalized for variations in transfection efficiency against renilla luciferase activity. Each independent experiment was performed a minimum of three times.
Fluorescent stains
The transfected cells were fixed with 3% paraformaldehyde containing 0.1% Triton X-100 for 30 min. After extensive PBS washes, the cells were stained with DAPI (0.5 μg/ml) for 5 min at room temperature, protected from light. Transfected cells were directly stained with Calcein-AM (1 μM) and EthD-1 (2 μM) and incubated at 37 
Western blot analysis
Approximately 2.5 × 10 5 HEK293T or HeLa cells were seeded into each of six culture plate wells, and grown in DMEM with 10% FBS for 24 hours. 3 μg pcDB-HS1BP3 or pcDB were transfected into the cells in each well. 24 hours post-transfection, the cells were harvested and incubated with 100 μl lysis buffer (1 × PBS, 1% nonyl phenoxylpolyethoxylethanol (NP40), 0.5% sodium deoxycholate, 0.1% sodium docecyl sulfate (SDS)) on wet ice for 30 min, then centrifuged at 12,000 rpm for 10 min at 4 o C, the aqueous phase was then extracted. The total protein concentrations were measured with a bicinchoninic acid (BCA) protein assay kit (Pierce, USA) according to the manufacturer's instructions. Total protein was loaded at 30 μg per lane for electrophoresis. For immunoblotting analysis we used antibodies against PARP and GAPDH. All antibodies were obtained from Cell Signaling Company, Ltd. Horseradish peroxidase (HRP)-conjugated secondary antibodies against mouse and rabbit IgG were purchased from Santa Cruz Biotechnology, Inc. The antibody reactivity was visualized using Enhanced Chemiluminescent Substrate (Invitrogen).
Detection of PS externalization
Transfected cells (2 × 10 5 ) were trypsinized, washed twice with PBS, and resuspended in 200 μl binding buffer (10 mM 4-(2-hydroxymethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4, 140 mM NaCl, 1 mM MgCl2, 5 mM KCl, 2.5 mM CaCl2). FITC-conjugated Annexin V was added to a final concentration of 0.5 μg/ml. After incubation for 20 min at room temperature and protected from light, PI was added at 1 μg/ml, and the samples were immediately analyzed on a FACSCalibur flow cytometer (Becton Dickinson, USA). 1 × 10 4 cells were collected and the percent of observed cells that were apoptotic was recorded.
